277 related articles for article (PubMed ID: 34635393)
1. RORγt protein modifications and IL-17-mediated inflammation.
Kumar R; Theiss AL; Venuprasad K
Trends Immunol; 2021 Nov; 42(11):1037-1050. PubMed ID: 34635393
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis.
Xue X; Soroosh P; De Leon-Tabaldo A; Luna-Roman R; Sablad M; Rozenkrants N; Yu J; Castro G; Banie H; Fung-Leung WP; Santamaria-Babi L; Schlueter T; Albers M; Leonard K; Budelsky AL; Fourie AM
Sci Rep; 2016 Dec; 6():37977. PubMed ID: 27905482
[TBL] [Abstract][Full Text] [Related]
3. Post-translational regulation of RORγt-A therapeutic target for the modulation of interleukin-17-mediated responses in autoimmune diseases.
Rutz S; Eidenschenk C; Kiefer JR; Ouyang W
Cytokine Growth Factor Rev; 2016 Aug; 30():1-17. PubMed ID: 27481185
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL
Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: Ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing RORγt.
Yang J; Xu P; Han L; Guo Z; Wang X; Chen Z; Nie J; Yin S; Piccioni M; Tsun A; Lv L; Ge S; Li B
J Immunol; 2015 May; 194(9):4094-7. PubMed ID: 25821221
[TBL] [Abstract][Full Text] [Related]
6. RORγt expression in T
Kluger MA; Nosko A; Ramcke T; Goerke B; Meyer MC; Wegscheid C; Luig M; Tiegs G; Stahl RA; Steinmetz OM
Clin Exp Immunol; 2017 Apr; 188(1):63-78. PubMed ID: 27880975
[TBL] [Abstract][Full Text] [Related]
7. TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORγt in Promoting IL-17A Expression.
Wang X; Yang J; Han L; Zhao K; Wu Q; Bao L; Li Z; Lv L; Li B
J Biol Chem; 2015 Nov; 290(48):29086-94. PubMed ID: 26453305
[TBL] [Abstract][Full Text] [Related]
8. Pak2-mediated phosphorylation promotes RORγt ubiquitination and inhibits colonic inflammation.
Kathania M; Kumar R; Lenou ET; Basrur V; Theiss AL; Chernoff J; Venuprasad K
Cell Rep; 2022 Sep; 40(11):111345. PubMed ID: 36103814
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
10. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesis.
Shapiro M; Nandi B; Pai C; Samur MK; Pelluru D; Fulciniti M; Prabhala RH; Munshi NC; Gold JS
Cancer Immunol Immunother; 2016 Jan; 65(1):13-24. PubMed ID: 26559812
[TBL] [Abstract][Full Text] [Related]
12. RORγt phosphorylation protects against T cell-mediated inflammation.
Ma S; Patel SA; Abe Y; Chen N; Patel PR; Cho BS; Abbasi N; Zeng S; Schnabl B; Chang JT; Huang WJM
Cell Rep; 2022 Mar; 38(11):110520. PubMed ID: 35294872
[TBL] [Abstract][Full Text] [Related]
13. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer.
Punkenburg E; Vogler T; Büttner M; Amann K; Waldner M; Atreya R; Abendroth B; Mudter J; Merkel S; Gallmeier E; Rose-John S; Neurath MF; Hildner K
Gut; 2016 Jul; 65(7):1139-50. PubMed ID: 25838550
[TBL] [Abstract][Full Text] [Related]
14. Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses.
Ecoeur F; Weiss J; Kaupmann K; Hintermann S; Orain D; Guntermann C
Front Immunol; 2019; 10():577. PubMed ID: 30972071
[TBL] [Abstract][Full Text] [Related]
15. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
[TBL] [Abstract][Full Text] [Related]
16. Transcription of RORγt in developing Th17 cells is regulated by E-proteins.
Zhang F; Fuss IJ; Yang Z; Strober W
Mucosal Immunol; 2014 May; 7(3):521-32. PubMed ID: 24064669
[TBL] [Abstract][Full Text] [Related]
17. RORγt inhibition ameliorates IL-23 driven experimental psoriatic arthritis by predominantly modulating γδ-T cells.
Mortier C; Gracey E; Coudenys J; Manuello T; Decruy T; Maelegheer M; Stappers F; Gilis E; Gaublomme D; Van Hoorebeke L; Van Welden S; Ambler C; Hegen M; Symanowicz P; Steyn S; Berstein G; Elewaut D; Venken K
Rheumatology (Oxford); 2023 Sep; 62(9):3169-3178. PubMed ID: 36661300
[TBL] [Abstract][Full Text] [Related]
18. Sumoylation of RORγt regulates T
He Z; Zhang J; Huang Z; Du Q; Li N; Zhang Q; Chen Y; Sun Z
Nat Commun; 2018 Nov; 9(1):4870. PubMed ID: 30451821
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of RORγt suppresses the Th17 pathway and alleviates arthritis in vivo.
Guendisch U; Weiss J; Ecoeur F; Riker JC; Kaupmann K; Kallen J; Hintermann S; Orain D; Dawson J; Billich A; Guntermann C
PLoS One; 2017; 12(11):e0188391. PubMed ID: 29155882
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
Qiu J; Zhou L
Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
